|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1998-10-22
|
|
pubmed:abstractText |
Febrile neutropenia in patients who have undergone chemotherapy is usually treated with a combination of broad-spectrum antibiotics. There are no exactly defined protocols for single-agent treatment because a clear definition of low risk febrile neutropenia is lacking. This paper examines the safety and efficacy of once-daily ceftriaxone in 376 cases.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0009-3157
|
|
pubmed:author |
pubmed-author:EgererGG,
pubmed-author:FrankeAA,
pubmed-author:HeimFF,
pubmed-author:JürgensHH,
pubmed-author:KämpfeDD,
pubmed-author:KarthausMM,
pubmed-author:KullmannK HKH,
pubmed-author:PetersGG,
pubmed-author:RitterJJ,
pubmed-author:SüdhoffTT,
pubmed-author:WolfH HHH
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
44
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
343-54
|
|
pubmed:dateRevised |
2009-11-11
|
|
pubmed:meshHeading |
pubmed-meshheading:9732151-Adolescent,
pubmed-meshheading:9732151-Adult,
pubmed-meshheading:9732151-Aged,
pubmed-meshheading:9732151-Aged, 80 and over,
pubmed-meshheading:9732151-Antineoplastic Agents,
pubmed-meshheading:9732151-Blood Cell Count,
pubmed-meshheading:9732151-Ceftriaxone,
pubmed-meshheading:9732151-Cephalosporins,
pubmed-meshheading:9732151-Child,
pubmed-meshheading:9732151-Child, Preschool,
pubmed-meshheading:9732151-Female,
pubmed-meshheading:9732151-Fever,
pubmed-meshheading:9732151-Humans,
pubmed-meshheading:9732151-Infant,
pubmed-meshheading:9732151-Male,
pubmed-meshheading:9732151-Middle Aged,
pubmed-meshheading:9732151-Neutropenia,
pubmed-meshheading:9732151-Prospective Studies,
pubmed-meshheading:9732151-Treatment Outcome
|
|
pubmed:articleTitle |
Ceftriaxone monotherapy in the treatment of low-risk febrile neutropenia.
|
|
pubmed:affiliation |
Department of Hematology, Medizinische Hochschule Hannover, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
